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Abstract Various studies have provided evidence for the
existence of spontaneously active cytosolic species of protein
phosphatase 1, but these enzymes have never been purified and
characterized. We have used chromatography on microcystin-
Sepharose and Resource Q to purify cytosolic protein phospha-
tases from rat liver. Two of the isolated enzymes were identified
by Western analysis and peptide sequencing as complexes of the
catalytic subunit of protein phosphatase 1 and either the inhibitor
NIPP1 or the myosin-binding subunit MYPT1, which reportedly
is not present in chicken liver. In contrast, PCR cloning revealed
the expression of two MYPT1 splice variants in rat liver.
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1. Introduction
Protein phosphatase (PP) 1 and PP2A represent two major
subfamilies of Ser/Thr protein phosphatases [1,2]. With phos-
phorylase a as substrate they account together for nearly all
the protein phosphatase activity in crude tissue and cell frac-
tions. Protein phosphatases of types 1 and 2A contain a struc-
turally related catalytic subunit, but they can easily be di¡er-
entiated biochemically by their distinct sensitivity to toxins
(e.g. microcystin-LR) and protein inhibitors (e.g. inhibitor-
2). The catalytic subunits of PP1 and PP2A do not exist freely
in the cell but are associated with polypeptides that control
the activity, substrate speci¢city and intracellular location of
the phosphatase. PP2A holoenzymes consist of the catalytic
subunit (PP2AC), a constant A-subunit (PR65) and a variable
third subunit or B-subunit. The type-1 holoenzymes usually
contain, in addition to the catalytic subunit (PP1C), only one
regulatory subunit.
While most PP2A is soluble after homogenization and tis-
sue fractionation, a large fraction of PP1 is sedimentable. This
can be explained by the anchoring of speci¢c PP1 holoen-
zymes to glycogen particles, ribosomes, endoplasmic reticu-
lum, contractile elements and nuclei [1^4]. However, cytosolic
species of PP1 have also been described. One of these repre-
sents an inactive heterodimeric complex between the catalytic
subunit and inhibitor-2 [1]. In addition, several reports de-
scribed spontaneously active species of PP1 in the cytosol,
varying in size between 68 and 260 kDa [5^8]. The latter
enzymes have never been characterized in more detail, how-
ever, largely because of problems with proteolysis during fur-
ther puri¢cation.
Signi¢cant progress in the puri¢cation of PP1 holoenzymes
has been made by the use of microcystin a⁄nity chromatog-
raphy [9,10]. This a⁄nity chromatography is based upon the
covalent binding of PP1C, either free or associated with reg-
ulatory subunits, to microcystin [11] and the subsequent dis-
ruption of this bond by KSCN [9,12]. Haystead and co-work-
ers developed a variant of this method whereby PP1
holoenzymes were eluted from avidin-Sepharose as a complex
with microcystin-biotin [10]. We report here the use of micro-
cystin-Sepharose for the puri¢cation of PP1 holoenzymes
from rat liver cytosol. Furthermore, we have identi¢ed the
regulatory subunits of two of these enzymes as MYPT1 and
NIPP1, which were originally described as myosin-associated
and nuclear regulators of PP1, respectively [4,13].
2. Materials and methods
2.1. Materials and assays
PP1C [14] and phosphorylase b [15] were puri¢ed from rabbit skel-
etal muscle. Inhibitor-2 was puri¢ed from heat-treated lysates from
BL21(DE3) cells transformed with pET8d-inhibitor-2 plasmid (kindly
provided by Dr. A.A. DePaoli-Roach), using chromatography on blue
Sepharose [16]. Rabbit muscle myosin was obtained from Sigma.
Phosphorylase and myosin were phosphorylated by phosphorylase
kinase and myosin light-chain kinase, respectively, in the presence
of [Q32P]ATP. The digoxigenin protein labelling and detection kit
was purchased from Roche Diagnostics. Microcystin-LR from ICN
was coupled to CH-Sepharose as described [9].
A synthetic peptide comprising the carboxy-terminal 10 residues of
the N-isoform of human PP1C was coupled to bovine serum albumin,
using glutaraldehyde [17], and used to raise antibodies in rabbits. The
antibodies were puri¢ed by chromatography on A⁄-T agarose. A
peptide with the sequence of residues 341^351 of bovine NIPP1,
plus an additional carboxy-terminal cysteine, was coupled to keyhole
limpet hemocyanin and to bovine serum albumin, using the Pierce
immunogen conjugation kit. Rabbit polyclonal antibodies against
the hemocyanin-coupled peptide were a⁄nity puri¢ed on albumin-
coupled peptide linked to CNBr-activated Sepharose 4B. Rabbit anti-
serum against the N-terminal 38 residues of chicken MYPT1 was
kindly provided by Dr. D. Hartshorne (University of Arizona, USA).
2.2. Puri¢cation of cytosolic protein phosphatases
The livers of ¢ve female Wistar rats (200 g) were homogenized with
a Potter-Elvehjem device in two volumes of a bu¡er containing 50
mM Tris at pH 7.4, 0.5 mM dithiothreitol, 1 mM EGTA, 1 mM
EDTA, 0.25 M sucrose, 0.5 mM phenylmethylsulfonyl £uoride, 0.5
mM benzamidine and 5 WM leupeptin. After centrifugation for 10 min
at 10 000Ug, the low-speed supernatant was re-centrifuged for 35 min
at 170 000Ug. The second supernatant is further referred to as the
‘cytosolic fraction’.
The cytosolic fraction (80 ml) was supplemented with 0.3 M NaCl
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and applied to a microcystin-Sepharose column (3 ml) that was equi-
librated in bu¡er A (50 mM glycylglycine at pH 7.4, 0.5 mM dithio-
threitol, 5 mM 2-mercaptoethanol, 0.5 mM phenylmethylsulfonyl £u-
oride, 0.5 mM benzamidine and 5 WM leupeptin) plus 0.3 M NaCl.
The retained proteins were eluted with bu¡er A plus 3 M KSCN.
After extensive dialysis against bu¡er A, the eluate (18 ml) was ap-
plied to a Resource Q column (1 ml; Amersham Pharmacia Biotech)
that had been equilibrated in bu¡er A with 50 mM NaCl. The pro-
teins were eluted with a 50 ml gradient of 50^1000 mM NaCl. The
eluted fractions were assayed for spontaneous and trypsin-revealed
phosphorylase phosphatase activities as described by Beullens et al.
[18].
2.3. Peptide sequencing
Phosphatase pools B, C and D from Resource Q (see Fig. 1) were
incubated overnight with either modi¢ed trypsin (Roche; 5 Wg/ml) at
37‡C or Staphylococcus aureus SV8 protease (25 Wg/ml) at 22‡C. After
addition of 0.1% tri£uoroacetic acid, the digest was applied to a C2/
C18 reversed-phase column (0.35 ml; Amersham Pharmacia Biotech),
which was eluted with a gradient of 0^70% acetonitrile in 0.1% tri-
£uoroacetic acid. The eluted peptides, as detected by absorbance
measurements at 215 nm, were collected manually and sequenced
with an Applied Biosystems Procise (model 492) protein sequencer
in the pulsed liquid mode.
2.4. Northern and (far-)Western analysis
Total RNA was isolated from 100^500 mg of frozen cells or pulv-
erized rat tissues by CsCl gradient centrifugation [19]. The RNA was
fractionated by electrophoresis (30 Wg/lane) in formaldehyde-agarose
(1%) gels and transferred by capillary di¡usion to nylon membranes.
The membranes were hybridized with cDNAs encoding nt 430^1923
(A of initiation codon taken as nt 1) of isoform 3 of rat aorta MYPT1
[13] or with 18S ribosomal cDNA, labelled to a speci¢c radioactivity
of 2U109 cpm/Wg by random priming (Life Technologies, Inc). Hy-
bridizations were performed overnight at 65‡C in 5USSC, 20 mmol/l
phosphate (pH 6.5), 1UDenhardt’s solution, 8% dextran sulfate, and
100 Wg/ml salmon sperm DNA. Subsequently, the membranes were
washed twice for 15 min at room temperature in 2USSC/0.1% SDS
and twice for 15 min at 65‡C in 0.2USSC/0.1% SDS. The hybridized
cDNA was visualized by phosphor image analysis.
The PP1CN and NIPP1 antibodies were used at a ¢nal concentration
of 1 Wg/ml. The MYPT1 antiserum was used at a ¢nal dilution of 1/
10 000. The peroxidase-labelled secondary antibodies were detected by
enhanced chemiluminescence. Far-Western blotting using digoxigenin-
labelled PP1C was performed as described by Beullens et al. [18].
2.5. The cloning of rat liver MYPT1
A rat liver cDNA library (Stratagene) was used as a template for
several PCR-reactions with rTaq DNA polymerase (TaKaRa Biomed-
icals) and di¡erent sets of primers that were deduced from the se-
quence of the rat aorta MYPT1 isoform 1 [13]. The sense-primers
were: 5P-TCGCGATAAGAAGAGCCGGCGGCA-3P, 5P-GATATT-
GCAGAGGAGGAAGCAATG-3P, 5P-TTGTGGGCTGAGGATA-
GTACT-3P and 5P-AAACGGAGGTCTACTGGAGT-3P. The anti-
sense primers were: 5P-TTCCTCTTCTTTTCGAGCTGCTTC-3P, 5P-
AGCACTTACAACAGTTGGAGCAA-3P, 5P-GGAGCCATCCTC-
GGTGTCTGACT-3P and 5P-TCCTAGATAAGAGGGCGTTTGG-
CA-3P. The PCR products were analyzed by gel electrophoresis and
Southern blotting, and the essential fragments were cloned into the
pGEM-T easy vector (Promega). DH5K cells (Life Technologies) were
transformed with these plasmids and the inserts were sequenced in an
automated laser £uorescent DNA sequencer (Amersham Pharmacia
Biotech).
3. Results
3.1. Puri¢cation of cytosolic protein phosphatases
Following chromatography of a rat liver cytosolic fraction
on microcystin-Sepharose (not shown), the phosphorylase
phosphatase activity in the eluate could be further fractio-
nated into four peaks (A^D) by anion exchange chromatog-
raphy on Resource Q (Fig. 1). The phosphatase activity in all
four peaks was completely blocked by 0.7 WM inhibitor-2,
showing that the activity stemmed exclusively from PP1.
The presence of PP1C in pools A^D was con¢rmed by West-
ern analysis (not illustrated). The phosphorylase phosphatase
activity in peaks A, C and D was stimulated severalfold by
preincubation with trypsin (Fig. 1). Since trypsin barely a¡ects
the phosphorylase phosphatase activity of the free catalytic
subunit [18], this suggested that the activity of PP1C in these
fractions was restrained by associated regulatory subunits. By
contrast, peak B behaved as free PP1C ; indeed, it migrated
during gel ¢ltration on Superdex 75 (Amersham Pharmacia
Biotech) as a protein of about 40 kDa (not shown) and its
phosphorylase phosphatase activity was somewhat inhibited
by trypsin (Fig. 1). Furthermore, the N-terminal sequences
of all six tryptic peptides that could be obtained from pool
B were contained in PP1C (Table 1). The sequences obtained
did not allow us, however, to identify the PP1C isoform(s)
present in pool B.
The phosphatase in pool A showed a very low spontaneous
activity (Fig. 1) and migrated during gel ¢ltration as a protein
of about 90 kDa (not shown). This was reminiscent of
PP1NNIPP1, which was identi¢ed in rat liver nuclei as a heter-
odimeric complex between PP1C and the inhibitory protein
NIPP1 [4]. In further agreement with the presence of NIPP1
in pool A we found that a protein of the expected size (41
kDa on 10% Tricine-SDS-PAGE) could be detected by West-
ern analysis with antibodies against the carboxy-terminus of
NIPP1 and by far-Western analysis with digoxigenin-labelled
PP1C (not shown). Furthermore, NIPP1 in pool A could also
be shown to co-immunoprecipitate with PP1C (not illus-
trated), proving that both components formed a complex.
The fractions corresponding to pool C contained a protein
of 65 kDa that appeared homogeneous by Coomassie staining
(not illustrated). N-terminal sequencing of ¢ve peptides that
were obtained by treatment of pool C with S. aureus SV8
identi¢ed the 65 kDa polypeptide as the A-subunit of PP2A
(Table 1). Since no catalytic subunit of PP2A could be de-
tected in these fractions by Coomassie staining or by phos-
phorylase phosphatase assays in the presence of inhibitor-2,
we conclude that the A-subunit was eluted without associated
Fig. 1. Chromatography of cytosolic phosphorylase phosphatases on
Resource Q. The dialyzed eluate of microcystin-Sepharose was ap-
plied to a Resource Q column (1 ml). The retained proteins were
eluted with a salt gradient of 50 ml (solid line) and the fractions
(0.5 ml) were assayed for phosphorylase phosphatase activities, as
such (a), after preincubation of the fractions with trypsin (b), and
in the presence of 0.7 WM inhibitor-2 (R).
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catalytic subunit, in agreement with ¢ndings of Campos et al.
[10]. Apparently, the adopted elution procedure (3 M KSCN)
disrupted the PP2A holoenzyme structure but did not a¡ect
the covalent interaction between microcystin and PP2AC,
which remained associated with the a⁄nity column. On the
other hand, it is well established that KSCN breaks the co-
valent bond between PP1C and microcystin [9,12]. We did not
obtain any peptide sequence that enabled us to identify the
subunit(s) of the type 1 phosphorylase phosphatase that
eluted in pool C.
Sequencing of tryptic peptides revealed the presence of both
PP1CN and the myosin-phosphatase binding subunit MYPT1
in pool D (Table 1). MYPT1, as well as some proteolytic
fragments, could also be visualized in pool D by Western
analysis with antibodies against the N-terminus of MYPT1
and by far-Western blot analysis with digoxigenin-labelled
PP1C (Fig. 2). In further agreement with the presence of a
myosin phosphatase in pool D, we found that this pool de-
phosphorylated myosin that had been phosphorylated by the
myosin light chain kinase at a much faster rate than did free
PP1C, obtained by trypsinolysis of the holoenzyme (Fig. 3).
The speci¢c phosphorylase phosphatase activity of the pool of
puri¢ed PP1MMYPT1 amounted to 897 U/mg, which is close to
the value reported for the enzyme from chicken gizzard [20].
Thus, the Coomassie-stained bands in the pool of puri¢ed
PP1MMYPT1, in addition to that of intact MYPT1 (a doublet
of 110^115 kDa) and PP1C (ca. 35 kDa), are likely to repre-
sent proteolytic fragments of MYPT1. In further agreement
with this view, the major degradation product (55^60 kDa)
corresponds in size to a previously characterized proteolytic
fragment of MYPT1 in puri¢ed preparations of PP1M from
smooth muscle [21].
3.2. The cloning of rat liver MYPT1
The detection of MYPT1 in pool D was unexpected since
this ‘smooth muscle’ myosin-binding subunit was previously
reported not to be expressed in the liver [21,22]. We wondered
whether this discrepancy could perhaps be explained by the
existence of liver-speci¢c isoform(s) of MYPT1. Therefore, the
hepatic MYPT1 isoforms were PCR-cloned using a rat liver
cDNA library as template and primers based upon the cDNA
sequences of rat aorta MYPT1. The sequencing of overlap-
ping fragments covering the complete MYPT1 cDNA re-
vealed that rat liver contains two isoforms of MYPT1 (not
illustrated) that are identical to the rat aorta isoforms 1 and 3
[13]. These isoforms have calculated masses of 110 and 115
Table 1
Amino acid sequence of proteolytic peptides derived from Resource
Q pools B, C and D
Peptide sequence Found in (residue number)
Pool B
AHQVVEDGYEFFAK PP1C (246^259)
LFSAPNYXGEF PP1C (265^275)
IFXXHGGLSPDL PP1C (168^179)
IYGFYDEXXR PP1C (132^141)
GNHEXASIN PP1C (122^130)
TFTDXFNXLPIAAXVDEK PP1C (150^167)
Pool C
EXMPLXAXQXGV A-subunit of PP2A (473^484)
EAXFVPLV A-subunit of PP2A (173^180)
EXVQLR A-subunit of PP2A (71^76)
ELQKAV A-subunit of PP2A (317^322)
ETVVRD A-subunit of PP2A (149^154)
Pool D
WIXSETDLEPXVVK MYPT1 (17^30)
YQYTSLNSGRPVTP PP1CN (304^317)
The numbers in parentheses show the corresponding residues of rat
PP1CN (pools B and D), the human A-subunit (K-isoform) of PP2A,
and isoform 1 of rat aorta MYPT1.
Fig. 2. Identi¢cation of MYPT1 as a subunit of cytosolic PP1.
MYPT1 was visualized in pool D by Coomassie staining, by West-
ern analysis and by far-Western analysis with the digoxigenin-la-
belled catalytic subunit. The arrows indicate the position of the
marker proteins. The arrowheads indicate the position of migration
of intact MYPT1 (110^115 kDa) and PP1C (35^38 kDa).
Fig. 3. Rat liver cytosol contains a myosin phosphatase. Myosin,
phosphorylated by myosin light chain kinase, was incubated for 10
min as such, with an aliquot of pool D of the Resource Q column,
or with the same amount of pool D that had been preincubated
with trypsin to generate free PP1C. Subsequently, the assay mixture
was subjected to 7.5% Tricine-SDS-PAGE. The ¢gure shows an
autoradiogram of the dried gel.
Fig. 4. Tissue distribution of MYPT1 in the rat. Total RNA (30 Wg/
lane) of the indicated rat tissues and cells was fractionated by elec-
trophoresis and subsequently blotted onto nylon membranes. The
membranes were hybridized with cDNAs encoding 18S RNA or a
fragment (nt 430^1923) of rat aorta MYPT1 mRNA (isoform 3).
The ¢gure shows an autoradiogram of the hybridized membrane.
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kDa, respectively, and only di¡er by the absence (isoform 1)
or presence (isoform 3) of a 56 residue insert in the central
domain.
Northern blot analysis showed a major MYPT1 transcript
of 6.1 kb in all rat tissues investigated, except pancreas and
skeletal muscle (Fig. 4A). In addition, a 3.8 kb MYPT1 tran-
script was detected that was particularly abundant in testis.
The MYPT1 transcripts were equally abundant in rat liver
and rat hepatocytes and in FAO hepatoma cells (Fig. 4B),
showing that the detection of MYPT1 in liver cytosol cannot
be attributed to its expression in non-parenchymal cells.
MYPT1 could also be detected by Western blotting in the
cytosolic fraction from rat liver (not shown).
4. Discussion
Both cytosolic holoenzymes of PP1 that we have isolated
were originally described in a di¡erent context. PP1NNIPP1 has
previously been characterized as a nuclear complex of PP1C
and NIPP1 [4]. By immunoblotting of hepatic fractions at the
same protein concentration, NIPP1 could be readily detected
in the nuclear fraction but not in the cytosolic fraction [23].
Given the larger volume and protein concentration of the
cytosolic fraction these ¢ndings do not rule out the possibility,
however, that a signi¢cant fraction of hepatic NIPP1 is cyto-
solic. It cannot be excluded either that the detection of a
‘cytosolic’ PP1NNIPP1 (this work) is an artefact, resulting
from nuclear leakage during tissue fractionation.
The myosin-associated phosphatase PP1MMYPT1 was
known to be present in several chicken tissues [21] except
for skeletal muscle, which contains a distinct type of PP1M
[24], and liver, which reportedly did not contain MYPT1 pro-
tein [21] or mRNA [22]. Unexpectedly, our results show that
PP1MMYPT1 is indeed present in rat liver, and that the con-
centration of MYPT1 transcripts in liver parenchymal cells is
at least as high as that in total liver.
In non-muscle cells phosphorylation of the myosin light
chains by a speci¢c Ca2/calmodulin-activated kinase enables
myosin to interact with actin and to assemble into micro¢la-
ments (also known as stress ¢bers or focal adhesions) that
play a role in phagocytosis, cytokinesis and organelle move-
ments. By its ability to dephosphorylate myosin light chains
PP1MMYPT1 causes the disruption of micro¢laments and the
release of myosin as a free cytosolic protein. Since myosin is
expected to be rapidly dephosphorylated by PP1MMYPT1 after
tissue homogenization, for lack of an opposing kinase action,
both myosin and PP1MMYPT1 are expected to be present in
the cytosolic fraction, which agrees with our observations.
In conclusion, we have identi¢ed two species of PP1 in rat
liver cytosol as PP1MMYPT1 and PP1NNIPP1. We propose that
these holoenzymes account, at least in part, for the previous-
ly described ‘high-molecular-weight’ cytosolic phosphatases
[5^8].
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